ID   C1TC_HUMAN              Reviewed;         935 AA.
AC   P11586; B2R5Y2; Q86VC9; Q9BVP5;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   21-MAR-2012, entry version 145.
DE   RecName: Full=C-1-tetrahydrofolate synthase, cytoplasmic;
DE            Short=C1-THF synthase;
DE   Includes:
DE     RecName: Full=Methylenetetrahydrofolate dehydrogenase;
DE              EC=1.5.1.5;
DE   Includes:
DE     RecName: Full=Methenyltetrahydrofolate cyclohydrolase;
DE              EC=3.5.4.9;
DE   Includes:
DE     RecName: Full=Formyltetrahydrofolate synthetase;
DE              EC=6.3.4.3;
GN   Name=MTHFD1; Synonyms=MTHFC, MTHFD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 2-31.
RC   TISSUE=Liver;
RX   MEDLINE=89034046; PubMed=3053686;
RA   Hum D.W., Bell A.W., Rozen R., Mackenzie R.E.;
RT   "Primary structure of a human trifunctional enzyme. Isolation of a
RT   cDNA encoding methylenetetrahydrofolate dehydrogenase-
RT   methenyltetrahydrofolate cyclohydrolase-formyltetrahydrofolate
RT   synthetase.";
RL   J. Biol. Chem. 263:15946-15950(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-653.
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLN-653.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLN-653 AND
RP   PHE-769.
RC   TISSUE=Brain, Eye, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-17.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-17; 251-264; 314-324; 355-362; 596-616 AND
RP   722-733, CLEAVAGE OF INITIATOR METHIONINE, LACK OF N-TERMINAL
RP   ACETYLATION, AND MASS SPECTROMETRY.
RC   TISSUE=Foreskin fibroblast, and Prostatic carcinoma;
RA   Bienvenut W.V., Gao M., Leug H., Campbell A., Ozanne B.W.;
RL   Submitted (JUL-2009) to UniProtKB.
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-553, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 1-302.
RX   MEDLINE=98179934; PubMed=9519408; DOI=10.1016/S0969-2126(98)00019-7;
RA   Allaire M., Li Y., Mackenzie R.E., Cygler M.;
RT   "The 3-D structure of a folate-dependent dehydrogenase/cyclohydrolase
RT   bifunctional enzyme at 1.5-A resolution.";
RL   Structure 6:173-182(1998).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 1-306 IN COMPLEX WITH NADP
RP   AND SUBSTRATE ANALOGS, SUBUNIT, AND MUTAGENESIS OF SER-49; TYR-52;
RP   LYS-56 AND CYS-147.
RX   PubMed=10828945; DOI=10.1021/bi992734y;
RA   Schmidt A., Wu H., MacKenzie R.E., Chen V.J., Bewly J.R., Ray J.E.,
RA   Toth J.E., Cygler M.;
RT   "Structures of three inhibitor complexes provide insight into the
RT   reaction mechanism of the human methylenetetrahydrofolate
RT   dehydrogenase/cyclohydrolase.";
RL   Biochemistry 39:6325-6335(2000).
RN   [11]
RP   ASSOCIATION OF VARIANT HIS-293 WITH SUSCEPTIBILITY TO FS-NTD, AND
RP   VARIANT GLN-653.
RX   MEDLINE=98272628; PubMed=9611072;
RA   Hol F.A., van der Put N.M.J., Geurds M.P.A., Heil S.G.,
RA   Trijbels F.J.M., Hamel B.C.J., Mariman E.C.M., Blom H.J.;
RT   "Molecular genetic analysis of the gene encoding the trifunctional
RT   enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase,
RT   methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate
RT   synthetase) in patients with neural tube defects.";
RL   Clin. Genet. 53:119-125(1998).
RN   [12]
RP   ASSOCIATION OF VARIANT GLN-653 WITH SUSCEPTIBILITY TO FS-NTD, AND
RP   VARIANT LYS-134.
RX   PubMed=12384833; DOI=10.1086/344213;
RA   Brody L.C., Conley M., Cox C., Kirke P.N., McKeever M.P., Mills J.L.,
RA   Molloy A.M., O'Leary V.B., Parle-McDermott A., Scott J.M.,
RA   Swanson D.A.;
RT   "A polymorphism, R653Q, in the trifunctional enzyme
RT   methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate
RT   cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic
RT   risk factor for neural tube defects: report of the Birth Defects
RT   Research Group.";
RL   Am. J. Hum. Genet. 71:1207-1215(2002).
RN   [13]
RP   ASSOCIATION OF VARIANT GLN-653 WITH SUSCEPTIBILITY TO FS-NTD, AND
RP   VARIANT LYS-134.
RX   PubMed=16552426; DOI=10.1038/sj.ejhg.5201603;
RA   Parle-McDermott A., Kirke P.N., Mills J.L., Molloy A.M., Cox C.,
RA   O'Leary V.B., Pangilinan F., Conley M., Cleary L., Brody L.C.,
RA   Scott J.M.;
RT   "Confirmation of the R653Q polymorphism of the trifunctional C1-
RT   synthase enzyme as a maternal risk for neural tube defects in the
RT   Irish population.";
RL   Eur. J. Hum. Genet. 14:768-772(2006).
RN   [14]
RP   VARIANT LYS-134, AND ASSOCIATION WITH COLORECTAL CANCER
RP   SUSCEPTIBILITY.
RX   PubMed=17000706; DOI=10.1093/hmg/ddl401;
RA   Webb E.L., Rudd M.F., Sellick G.S., El Galta R., Bethke L., Wood W.,
RA   Fletcher O., Penegar S., Withey L., Qureshi M., Johnson N.,
RA   Tomlinson I., Gray R., Peto J., Houlston R.S.;
RT   "Search for low penetrance alleles for colorectal cancer through a
RT   scan of 1467 non-synonymous SNPs in 2575 cases and 2707 controls with
RT   validation by kin-cohort analysis of 14 704 first-degree relatives.";
RL   Hum. Mol. Genet. 15:3263-3271(2006).
RN   [15]
RP   CHARACTERIZATION OF VARIANT GLN-653, AND ASSOCIATION WITH RISK OF
RP   CONGENITAL HEART DEFECTS.
RX   PubMed=18767138; DOI=10.1002/humu.20830;
RA   Christensen K.E., Rohlicek C.V., Andelfinger G.U., Michaud J.,
RA   Bigras J.-L., Richter A., Mackenzie R.E., Rozen R.;
RT   "The MTHFD1 p.Arg653Gln variant alters enzyme function and increases
RT   risk for congenital heart defects.";
RL   Hum. Mutat. 30:212-220(2009).
CC   -!- CATALYTIC ACTIVITY: 5,10-methylenetetrahydrofolate + NADP(+) =
CC       5,10-methenyltetrahydrofolate + NADPH.
CC   -!- CATALYTIC ACTIVITY: 5,10-methenyltetrahydrofolate + H(2)O = 10-
CC       formyltetrahydrofolate.
CC   -!- CATALYTIC ACTIVITY: ATP + formate + tetrahydrofolate = ADP +
CC       phosphate + 10-formyltetrahydrofolate.
CC   -!- PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion.
CC   -!- SUBUNIT: Homodimer.
CC   -!- INTERACTION:
CC       P23508:MCC; NbExp=1; IntAct=EBI-709638, EBI-307531;
CC       Q9Y4K3:TRAF6; NbExp=1; IntAct=EBI-709638, EBI-359276;
CC       Q9P2S5:WDR8; NbExp=1; IntAct=EBI-709638, EBI-1054904;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: This trifunctional enzyme consists of two major domains:
CC       an N-terminal part containing the methylene-THF dehydrogenase and
CC       cyclohydrolase activities and a larger C-terminal part containing
CC       formyl-THF synthetase activity.
CC   -!- DISEASE: Defects in MTHFD1 may be a cause of susceptibility to
CC       folate-sensitive neural tube defects (FS-NTD) [MIM:601634]. The
CC       most common NTDs are open spina bifida (myelomeningocele) and
CC       anencephaly. Genetic defects in MTHFD1 may affect the risk of
CC       spina bifida via the maternal rather than the embryonic genotype.
CC   -!- DISEASE: Genetic variation in MTHFD1 could be associated with
CC       susceptibility to colorectal cancer (CRC) [MIM:114500].
CC   -!- SIMILARITY: In the N-terminal section; belongs to the
CC       tetrahydrofolate dehydrogenase/cyclohydrolase family.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the formate--
CC       tetrahydrofolate ligase family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J04031; AAA59574.1; -; mRNA.
DR   EMBL; AK312361; BAG35279.1; -; mRNA.
DR   EMBL; CH471061; EAW80857.1; -; Genomic_DNA.
DR   EMBL; BC001014; AAH01014.2; -; mRNA.
DR   EMBL; BC009806; AAH09806.1; -; mRNA.
DR   EMBL; BC050420; AAH50420.1; -; mRNA.
DR   IPI; IPI00218342; -.
DR   PIR; A31903; A31903.
DR   RefSeq; NP_005947.3; NM_005956.3.
DR   UniGene; Hs.652308; -.
DR   PDB; 1A4I; X-ray; 1.50 A; A/B=1-301.
DR   PDB; 1DIA; X-ray; 2.20 A; A/B=1-306.
DR   PDB; 1DIB; X-ray; 2.70 A; A/B=1-306.
DR   PDB; 1DIG; X-ray; 2.20 A; A/B=1-306.
DR   PDBsum; 1A4I; -.
DR   PDBsum; 1DIA; -.
DR   PDBsum; 1DIB; -.
DR   PDBsum; 1DIG; -.
DR   ProteinModelPortal; P11586; -.
DR   SMR; P11586; 2-296, 319-933.
DR   IntAct; P11586; 6.
DR   MINT; MINT-5000922; -.
DR   STRING; P11586; -.
DR   PhosphoSite; P11586; -.
DR   DMDM; 115206; -.
DR   SWISS-2DPAGE; P11586; -.
DR   REPRODUCTION-2DPAGE; IPI00218342; -.
DR   PRIDE; P11586; -.
DR   DNASU; 4522; -.
DR   Ensembl; ENST00000216605; ENSP00000216605; ENSG00000100714.
DR   GeneID; 4522; -.
DR   KEGG; hsa:4522; -.
DR   UCSC; uc001xhb.1; human.
DR   CTD; 4522; -.
DR   GeneCards; GC14P064854; -.
DR   H-InvDB; HIX0011731; -.
DR   HGNC; HGNC:7432; MTHFD1.
DR   HPA; HPA000704; -.
DR   HPA; HPA001290; -.
DR   HPA; HPA015006; -.
DR   MIM; 114500; phenotype.
DR   MIM; 172460; gene+phenotype.
DR   MIM; 601634; phenotype.
DR   neXtProt; NX_P11586; -.
DR   Orphanet; 26; Methylmalonic acidemia - homocystinuria.
DR   Orphanet; 3388; Neural tube defect.
DR   PharmGKB; PA31236; -.
DR   eggNOG; COG0190; -.
DR   HOVERGEN; HBG004916; -.
DR   InParanoid; P11586; -.
DR   KO; K00288; -.
DR   OrthoDB; EOG4GB75D; -.
DR   PhylomeDB; P11586; -.
DR   BioCyc; MetaCyc:MONOMER-11654; -.
DR   BRENDA; 6.3.4.3; 2681.
DR   Reactome; REACT_111217; Metabolism.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB00116; Tetrahydrofolic acid.
DR   NextBio; 17468; -.
DR   ArrayExpress; P11586; -.
DR   Bgee; P11586; -.
DR   CleanEx; HS_MTHFD1; -.
DR   Genevestigator; P11586; -.
DR   GermOnline; ENSG00000100714; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004329; F:formate-tetrahydrofolate ligase activity; TAS:Reactome.
DR   GO; GO:0004477; F:methenyltetrahydrofolate cyclohydrolase activity; TAS:Reactome.
DR   GO; GO:0004488; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity; IEA:EC.
DR   GO; GO:0004486; F:methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; TAS:Reactome.
DR   GO; GO:0046655; P:folic acid metabolic process; TAS:Reactome.
DR   GO; GO:0009396; P:folic acid-containing compound biosynthetic process; IEA:InterPro.
DR   GO; GO:0000105; P:histidine biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0009086; P:methionine biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006164; P:purine nucleotide biosynthetic process; IEA:UniProtKB-KW.
DR   InterPro; IPR000559; Formate_THF_ligase.
DR   InterPro; IPR020628; Formate_THF_ligase_CS.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR000672; THF_DH/CycHdrlase.
DR   InterPro; IPR020630; THF_DH/CycHdrlase_cat_dom.
DR   InterPro; IPR020867; THF_DH/CycHdrlase_CS.
DR   InterPro; IPR020631; THF_DH/CycHdrlase_NAD-bd_dom.
DR   Gene3D; G3DSA:3.40.50.720; NAD(P)-bd; 1.
DR   Pfam; PF01268; FTHFS; 1.
DR   Pfam; PF00763; THF_DHG_CYH; 1.
DR   Pfam; PF02882; THF_DHG_CYH_C; 1.
DR   PRINTS; PR00085; THFDHDRGNASE.
DR   PROSITE; PS00721; FTHFS_1; 1.
DR   PROSITE; PS00722; FTHFS_2; 1.
DR   PROSITE; PS00766; THF_DHG_CYH_1; 1.
DR   PROSITE; PS00767; THF_DHG_CYH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Amino-acid biosynthesis; ATP-binding;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Disease mutation; Histidine biosynthesis; Hydrolase; Ligase;
KW   Methionine biosynthesis; Multifunctional enzyme; NADP;
KW   Nucleotide-binding; One-carbon metabolism; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Purine biosynthesis; Reference proteome.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    935       C-1-tetrahydrofolate synthase,
FT                                cytoplasmic.
FT                                /FTId=PRO_0000199321.
FT   NP_BIND     172    174       NADP.
FT   NP_BIND     380    387       ATP (By similarity).
FT   REGION        2    305       Methylenetetrahydrofolate dehydrogenase
FT                                and cyclohydrolase.
FT   REGION       52     56       Substrate binding.
FT   REGION       99    101       Substrate binding.
FT   REGION      272    276       Substrate binding.
FT   REGION      306    935       Formyltetrahydrofolate synthetase.
FT   BINDING     197    197       NADP.
FT   SITE          2      2       Not acetylated.
FT   MOD_RES     553    553       N6-acetyllysine.
FT   MOD_RES     786    786       Phosphothreonine (By similarity).
FT   VARIANT     134    134       R -> K (associated with increased risk of
FT                                colorectal cancer; dbSNP:rs1950902).
FT                                /FTId=VAR_016232.
FT   VARIANT     162    162       P -> L (in dbSNP:rs4902283).
FT                                /FTId=VAR_055458.
FT   VARIANT     293    293       R -> H (associated with susceptibility to
FT                                FS-NTD; dbSNP:rs34181110).
FT                                /FTId=VAR_010241.
FT   VARIANT     653    653       R -> Q (may be associated with
FT                                susceptibility to FS-NTD; decreases
FT                                enzyme stability and increases risk for
FT                                congenital heart defects;
FT                                dbSNP:rs2236225).
FT                                /FTId=VAR_010251.
FT   VARIANT     761    761       T -> M (in dbSNP:rs10813).
FT                                /FTId=VAR_032789.
FT   VARIANT     769    769       L -> F (in dbSNP:rs17857382).
FT                                /FTId=VAR_032790.
FT   MUTAGEN      49     49       S->A: No effect on dehydrogenase and
FT                                cyclohydrolase activity. Strong increase
FT                                of Km for NADP.
FT   MUTAGEN      49     49       S->Q: Reduces dehydrogenase by 75% and
FT                                cyclohydrolase activity by 99%. No effect
FT                                on Km for NADP and for 5,10-
FT                                methenyltetrahydrofolate.
FT   MUTAGEN      52     52       Y->A,S: Reduces dehydrogenase activity by
FT                                99%. Reduces cyclohydrolase activity by
FT                                70%. No effect on Km for NADP and for
FT                                5,10-methenyltetrahydrofolate.
FT   MUTAGEN      52     52       Y->F: Slightly reduces dehydrogenase and
FT                                cyclohydrolase activity. Increase of Km
FT                                for NADP and for 5,10-
FT                                methenyltetrahydrofolate.
FT   MUTAGEN      56     56       K->A,I,S,T: Decreases dehydrogenase
FT                                activity over 90%. Loss of cyclohydrolase
FT                                activity.
FT   MUTAGEN      56     56       K->E,M,Q: Moderate decrease of
FT                                dehydrogenase activity. Loss of
FT                                cyclohydrolase activity. Strong increase
FT                                of Km for NADP. Decrease of Km for 5,10-
FT                                methenyltetrahydrofolate.
FT   MUTAGEN      56     56       K->R: Reduces dehydrogenase and
FT                                cyclohydrolase activity by 99%. No effect
FT                                on Km for NADP and for 5,10-
FT                                methenyltetrahydrofolate.
FT   MUTAGEN     147    147       C->Q: Reduces dehydrogenase activity by
FT                                50% and cyclohydrolase activity by 87%.
FT   HELIX         9     30
FT   STRAND       37     44
FT   HELIX        47     63
FT   STRAND       66     72
FT   HELIX        78     90
FT   STRAND       96     99
FT   HELIX       111    116
FT   HELIX       120    122
FT   HELIX       129    136
FT   HELIX       147    157
FT   TURN        158    160
FT   STRAND      167    171
FT   TURN        175    177
FT   HELIX       178    187
FT   STRAND      191    195
FT   HELIX       202    206
FT   STRAND      210    214
FT   HELIX       224    226
FT   STRAND      232    235
FT   HELIX       258    261
FT   TURN        262    264
FT   STRAND      266    268
FT   STRAND      271    274
FT   HELIX       275    295
SQ   SEQUENCE   935 AA;  101559 MW;  29AE1C04B4922885 CRC64;
     MAPAEILNGK EISAQIRARL KNQVTQLKEQ VPGFTPRLAI LQVGNRDDSN LYINVKLKAA
     EEIGIKATHI KLPRTTTESE VMKYITSLNE DSTVHGFLVQ LPLDSENSIN TEEVINAIAP
     EKDVDGLTSI NAGRLARGDL NDCFIPCTPK GCLELIKETG VPIAGRHAVV VGRSKIVGAP
     MHDLLLWNNA TVTTCHSKTA HLDEEVNKGD ILVVATGQPE MVKGEWIKPG AIVIDCGINY
     VPDDKKPNGR KVVGDVAYDE AKERASFITP VPGGVGPMTV AMLMQSTVES AKRFLEKFKP
     GKWMIQYNNL NLKTPVPSDI DISRSCKPKP IGKLAREIGL LSEEVELYGE TKAKVLLSAL
     ERLKHRPDGK YVVVTGITPT PLGEGKSTTT IGLVQALGAH LYQNVFACVR QPSQGPTFGI
     KGGAAGGGYS QVIPMEEFNL HLTGDIHAIT AANNLVAAAI DARIFHELTQ TDKALFNRLV
     PSVNGVRRFS DIQIRRLKRL GIEKTDPTTL TDEEINRFAR LDIDPETITW QRVLDTNDRF
     LRKITIGQAP TEKGHTRTAQ FDISVASEIM AVLALTTSLE DMRERLGKMV VASSKKGEPV
     SAEDLGVSGA LTVLMKDAIK PNLMQTLEGT PVFVHAGPFA NIAHGNSSII ADRIALKLVG
     PEGFVVTEAG FGADIGMEKF FNIKCRYSGL CPHVVVLVAT VRALKMHGGG PTVTAGLPLP
     KAYIQENLEL VEKGFSNLKK QIENARMFGI PVVVAVNAFK TDTESELDLI SRLSREHGAF
     DAVKCTHWAE GGKGALALAQ AVQRAAQAPS SFQLLYDLKL PVEDKIRIIA QKIYGADDIE
     LLPEAQHKAE VYTKQGFGNL PICMAKTHLS LSHNPEQKGV PTGFILPIRD IRASVGAGFL
     YPLVGTMSTM PGLPTRPCFY DIDLDPETEQ VNGLF
//
